Impaired distal renal potassium handling in streptozotocin-induced diabetic mice

Am J Physiol Renal Physiol. 2024 Jul 1;327(1):F158-F170. doi: 10.1152/ajprenal.00240.2023. Epub 2024 May 23.

Abstract

Diabetes is closely associated with K+ disturbances during disease progression and treatment. However, it remains unclear whether K+ imbalance occurs in diabetes with normal kidney function. In this study, we examined the effects of dietary K+ intake on systemic K+ balance and renal K+ handling in streptozotocin (STZ)-induced diabetic mice. The control and STZ mice were fed low or high K+ diet for 7 days to investigate the role of dietary K+ intake in renal K+ excretion and K+ homeostasis and to explore the underlying mechanism by evaluating K+ secretion-related transport proteins in distal nephrons. K+-deficient diet caused excessive urinary K+ loss, decreased daily K+ balance, and led to severe hypokalemia in STZ mice compared with control mice. In contrast, STZ mice showed an increased daily K+ balance and elevated plasma K+ level under K+-loading conditions. Dysregulation of the NaCl cotransporter (NCC), epithelial Na+ channel (ENaC), and renal outer medullary K+ channel (ROMK) was observed in diabetic mice fed either low or high K+ diet. Moreover, amiloride treatment reduced urinary K+ excretion and corrected hypokalemia in K+-restricted STZ mice. On the other hand, inhibition of SGLT2 by dapagliflozin promoted urinary K+ excretion and normalized plasma K+ levels in K+-supplemented STZ mice, at least partly by increasing ENaC activity. We conclude that STZ mice exhibited abnormal K+ balance and impaired renal K+ handling under either low or high K+ diet, which could be primarily attributed to the dysfunction of ENaC-dependent renal K+ excretion pathway, despite the possible role of NCC.NEW & NOTEWORTHY Neither low dietary K+ intake nor high dietary K+ intake effectively modulates renal K+ excretion and K+ homeostasis in STZ mice, which is closely related to the abnormality of ENaC expression and activity. SGLT2 inhibitor increases urinary K+ excretion and reduces plasma K+ level in STZ mice under high dietary K+ intake, an effect that may be partly due to the upregulation of ENaC activity.

Keywords: diabetes; dietary potassium intake; hyperkalemia; hypokalemia; renal potassium handling.

MeSH terms

  • Amiloride / pharmacology
  • Animals
  • Benzhydryl Compounds
  • Diabetes Mellitus, Experimental* / metabolism
  • Diabetic Nephropathies / etiology
  • Diabetic Nephropathies / metabolism
  • Diabetic Nephropathies / physiopathology
  • Epithelial Sodium Channels* / metabolism
  • Glucosides / pharmacology
  • Homeostasis
  • Hypokalemia / metabolism
  • Kidney / drug effects
  • Kidney / metabolism
  • Kidney / physiopathology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Potassium Channels, Inwardly Rectifying / genetics
  • Potassium Channels, Inwardly Rectifying / metabolism
  • Potassium* / metabolism
  • Potassium* / urine
  • Potassium, Dietary* / metabolism
  • Renal Elimination / drug effects
  • Sodium-Glucose Transporter 2
  • Sodium-Glucose Transporter 2 Inhibitors / pharmacology
  • Solute Carrier Family 12, Member 3 / genetics
  • Solute Carrier Family 12, Member 3 / metabolism
  • Streptozocin

Substances

  • Potassium
  • Potassium, Dietary
  • Epithelial Sodium Channels
  • Sodium-Glucose Transporter 2 Inhibitors
  • Potassium Channels, Inwardly Rectifying
  • Kcnj1 protein, mouse
  • Amiloride
  • Solute Carrier Family 12, Member 3
  • Slc5a2 protein, mouse
  • Glucosides
  • Slc12a3 protein, mouse
  • Streptozocin
  • dapagliflozin
  • Benzhydryl Compounds
  • Sodium-Glucose Transporter 2